Shopping Cart
Remove All
Your shopping cart is currently empty
BAY-593 is an orally active GGTase-I inhibitor capable of blocking YAP1/TAZ signaling in vivo, exhibiting antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $138 | 7-10 days | 7-10 days | |
| 5 mg | $286 | - | In Stock |
| Description | BAY-593 is an orally active GGTase-I inhibitor capable of blocking YAP1/TAZ signaling in vivo, exhibiting antitumor activity. |
| In vitro | BAY-593 (0.5 nM–10 μM; 72 h) inhibited HT-1080 and MDA-MB-231 cell proliferation with IC₅₀ values of 0.038/0.564 μM, respectively [1]. |
| In vivo | BAY-593 (2.5–20 mg/kg; oral; 14 days) exhibited dose-dependent antitumor activity in HT-1080 fibrosarcoma and MDA-MB-231 triple-negative breast cancer xenograft mouse models [1]. |
| Synonyms | BAY593, BAY 593 |
| Molecular Weight | 476.53 |
| Formula | C26H31F3N2O3 |
| Cas No. | 2413020-56-9 |
| Smiles | O(C)C1=C([C@H]2C3(CCN(C([C@]([C@@](F)(F)F)(OC)C4=CC=CC=C4)=O)CC3)CCNC2)C=CC=C1 |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 92 mg/mL (193.06 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.